US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (193)
  • Diseases & Conditions (3845)
  • Drug Delivery (175)
  • Therapeutic Area (6091)
  • Vaccines (594)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325411
12/10/2014 | published by: Plunkett Research, Ltd.
... will save countless hours of research. Key Findings: Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $21.2 billion by 2021. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry, including Average ...  |  read more...
USD 1,995
Gastric Ulcers - Pipeline Review, H2 2014
12/15/2014 | published by: Global Markets Direct
... therapeutic development for Gastric Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Japanese Encephalitis - Pipeline Review, H2 2014
12/15/2014 | published by: Global Markets Direct
... therapeutic development for Japanese Encephalitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Eagle Pharmaceuticals Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Eagle Pharmaceuticals Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Griffin Discoveries BV - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Griffin Discoveries BV’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Kolltan Pharmaceuticals, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Kolltan Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Meiji Seika Pharma Co., Ltd. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... Co., Ltd.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Meiji Seika Pharma Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug ...  |  read more...
USD 1,500
Parion Sciences, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Parion Sciences, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Seikagaku Corporation - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Seikagaku Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Spring Bank Pharmaceuticals, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Spring Bank Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ...  |  read more...
USD 1,500
SymBio Pharmaceuticals Limited - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of SymBio Pharmaceuticals Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Taisho Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Taisho Pharmaceutical Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ...  |  read more...
USD 1,500
Valens Therapeutics, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Valens Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Bangladesh Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... non-communicablediseases, this represents an epidemiological transition that will present new opportunities forpharmaceutical companies. Headline Expenditure Projections Pharmaceuticals: BDT138.81bn (USD1.78bn) in 2013 to BDT154.62bn (USD1.99bn) in 2014; +11.4%in local currency terms and +11.9% in US dollar ...  |  read more...
USD 1,295
Allergic Asthma - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... therapeutic development for Allergic Asthma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Esophageal Cancer - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... therapeutic development for Esophageal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Post-Operative Pain - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... therapeutic development for Post-Operative Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Retinitis Pigmentosa (Retinitis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
PhaseRx, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of PhaseRx, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Hemorrhagic Fever - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... therapeutic development for Hemorrhagic Fever, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Chemotherapy Induced Neutropenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Recurrent Glioblastoma Multiforme (GBM), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Protagonist Therapeutics Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Protagonist Therapeutics Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Critical Limb Ischemia - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Critical Limb Ischemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Nausea and Vomiting, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
< prev 1    3  4  5  6  7  8  9  10